Seattle biotech PhaseRx sold to Swiss buyer in bankruptcy case - Pug...

Seattle biotech PhaseRx sold to Swiss buyer in bankruptcy case
Puget Sound Business Journal (Seattle)
Roivant has agreed to pay $6 million in milestone payments to Hercules Capital Inc., which held about $5.2 million in PhaseRx debt at the time of the bankruptcy filing. PhaseRx had about $1.8 million in cash and cash equivalents at the time of its Dec ...